Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition

F Zhang1, M Taipale, A Heiskanen

  • 1Haartman Institute, Department of Virology, University of Helsinki, FIN-00014 Helsinki, Finland.

Oncogene
|October 11, 2001
PubMed

Insights

Transforming growth factor-beta (TGF-beta) regulates cell growth by downregulating Cdk6 kinase. Restoring Cdk6 activity prevents TGF-beta-induced cell cycle arrest, highlighting Cdk6

Area of Science:

  • Cell biology
  • Molecular biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) signaling is crucial for cell cycle regulation and growth arrest.
  • Cyclin-dependent kinases (CDKs) and their inhibitors (CDKIs) like p15(Ink4b) and p27(Kip1) are key players in cell cycle control.
  • The precise mechanisms by which TGF-beta regulates CDK complexes and CDKIs to induce cell cycle arrest are still being elucidated.

Purpose of the Study:

  • To investigate the role of Cyclin-dependent kinase 6 (Cdk6) in TGF-beta-induced cell cycle arrest.
  • To determine how TGF-beta-mediated downregulation of Cdk6 affects the activity of cyclin D- and E-type kinase complexes.
  • To elucidate the impact of Cdk6 on the association of p15(Ink4b) and p27(Kip1) with CDK complexes during TGF-beta-induced growth arrest.

Main Methods:

  • Utilized Mv1Lu mink epithelial cells for experimental studies.
  • Employed transient and stable expression of Cdk6 to assess its effect on TGF-beta mediated arrest.
  • Investigated the interaction of Cdk6 with p15(Ink4b) and p27(Kip1) using dominant-negative Cdk6 constructs.

Main Results:

  • TGF-beta was shown to downregulate Cdk6 expression in Mv1Lu cells.
  • Overexpression of Cdk6 in Mv1Lu cells conferred resistance to TGF-beta-induced growth arrest.
  • Ectopic Cdk6 expression sequestered p15(Ink4b) and maintained p27(Kip1) in cyclin D-complexes, preventing full cell cycle arrest.
  • Dominant-negative Cdk6, lacking kinase activity, failed to override the TGF-beta arrest, confirming the importance of Cdk6 kinase function.

Conclusions:

  • Downregulation of Cdk6 kinase activity is essential for TGF-beta to enforce G1-phase arrest.
  • TGF-beta-induced changes in Cdk6 levels alter the association of p15(Ink4b) and p27(Kip1) with cyclin D and E kinase complexes.
  • Cdk6 plays a critical role in mediating the cellular response to TGF-beta signaling, impacting cell cycle progression.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...